Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Antiviral Res ; 50(2): 129-37, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11369433

RESUMEN

We previously synthesized a thioetherphospholipid-AZT conjugate (3'-azido-3'-deoxy-5'-(1-hexadecylthio-2-methoxypropyl)-phosphothymidine, CP-102) with potent anti-HIV-1 activity and significant reduction in cell cytotoxicity compared to AZT alone. To study the cellular metabolism of the conjugate compound we synthesized a double-tritium-labeled thioetherphospholipid-AZT conjugate (3'-azido-3'-deoxy-5'-(1-[9,10-3H]-S-octadecylthio-2-O-methoxypropyl)-phosphothymidine-[methyl-3H], [3H]CP-102). The intracellular radioactive metabolic products of [3H]CP-102 treated human lymphoblastoid CEM-SS cells were analyzed by HPLC and thin-layer chromatography. Results of this investigation provide evidence that a putative intracellular lipid cleavage enzyme metabolizes [3H]CP-102 to form a thioetherdiglyceride compound that migrates with an authentic 1-S-octadecyl-2-O-methyl-thioglycerol standard on TLC. The thioetherdiglyceride metabolite did not react with the ninhydrin reagent indicating it did not contain a primary amine such as that found on serine or ethanolamine containing phospholipids. Also, the product did not contain a phosphatidic acid group based on migration characteristics in the TLC plate. The other major hydrophilic metabolite was 3'-azido-3'-deoxythymidine-[methyl-3H]-monophosphate (AZT-MP) with lesser amounts of AZT, AZT-DP and AZT-TP. In summary, the best interpretation of these data is that the thioetherphospholipid-AZT conjugate, [3H]CP-102, is cleaved by a putative intracellular lipid cleavage enzyme to release a thioetherdiglyceride compound and AZT-MP. The resulting AZT-MP was either dephosphorylated to AZT or sequentially phosphorylated to AZT-DP and, ultimately, to AZT-TP, the known inhibitory metabolite against HIV-1 reverse transcriptase. Phospholipid-nucleoside conjugates may provide a unique approach for developing anti-HIV-1 prodrugs that do not have a strict requirement for a nucleoside kinase for initial activation of the prodrug to an antiviral form.


Asunto(s)
Fármacos Anti-VIH/metabolismo , Linfocitos/metabolismo , Fosfolípidos/metabolismo , Zidovudina/metabolismo , Fármacos Anti-VIH/síntesis química , Fármacos Anti-VIH/química , Células Cultivadas , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Didesoxinucleótidos , VIH-1/efectos de los fármacos , Humanos , Fosfolípidos/síntesis química , Fosfolípidos/química , Tritio , Zidovudina/síntesis química , Zidovudina/química
2.
J Pharm Sci ; 88(11): 1169-74, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10564066

RESUMEN

The oral route is the preferred route of delivery for a large number of drug molecules. However, the intestinal epithelium presents a formidable barrier for delivery of drugs into systemic circulation. Phospholipids are among compounds that enhance the absorption of drugs across the intestinal epithelium. In this paper, we describe structure-activity relationships for phospholipid derivatives as enhancers of paracellular permeability across Caco-2 cell monolayers. In a series of 2-alkoxy-3-alkylamidopropylphosphocholine derivatives, compounds with a long chain at C-3 (R3) and short chain at C-2 (R2) were potent in causing a decrease in transepithelial electrical resistance (TEER) and an increase in mannitol transport, but also showed significant cytotoxicity. Compounds with 9-11 carbons at C-3 and 6-10 carbons at C-2 provided good separation (up to 2.7-fold) between activity and cytotoxicity. Notably, a good correlation (r2 = 0.93) was observed between EC(50) (TEER) [concentration that caused a drop in TEER to 50% of its control (untreated) value] and EC10x (mannitol) [concentration that caused 10-fold increase in mannitol transport over the control (untreated) value], confirming that a decrease in TEER is associated with enhanced permeability of the hydrophilic compounds across Caco-2 cell monolayers. Compounds with medium to long carbon chains at C-2 and C-3, and the total carbons in the alkyl chains > 20, showed poor activity and no cytotoxicity.


Asunto(s)
Células CACO-2/efectos de los fármacos , Células CACO-2/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Fosfatidilcolinas/química , Fosfatidilcolinas/farmacología , Células CACO-2/citología , Ácido Edético/farmacología , Impedancia Eléctrica , Humanos , Manitol/farmacocinética , Fosfatidilcolinas/síntesis química , Fosfatidilcolinas/toxicidad , Relación Estructura-Actividad , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Uniones Estrechas/fisiología
3.
J Med Chem ; 41(13): 2261-7, 1998 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-9632359

RESUMEN

A newly developed comparative molecular field analysis (CoMFA) technique, the cross-validated r2-guided region selection (CoMFA/q2-GRS) method, has been used to build a quantitative structure-activity relationship (3D-QSAR) for nonsteroidal estrogen receptor (ER) ligands. Ligands included in this study belong to a series of diethylstilbestrol (DES) and indenestrol analogues whose affinities for the mouse ER (mER) have been determined in our laboratory. The final model utilized 30 compounds and yielded a q2GRS (cross-validated r2, guided region selection) of 0.796, as compared to a q2 of 0.720 for conventional CoMFA, with a standard error of prediction of 0.594 at 3 principal components. This model was used to visualize steric and electrostatic features of the ligands that correspond with ER binding affinity. Results obtained from the CoMFA steric and electrostatic plots of this model have also been compared to information from the ER binding affinities of substituted estradiol analogues. This is in an effort to determine structural features of compounds in the CoMFA analysis that may correspond to those of the estradiol analogues and to further clarify the mode of binding of nonsteroidal ER ligands.


Asunto(s)
Estrógenos no Esteroides/química , Modelos Moleculares , Receptores de Estrógenos/metabolismo , Animales , Dietilestilbestrol/análogos & derivados , Dietilestilbestrol/química , Dietilestilbestrol/metabolismo , Estrógenos no Esteroides/metabolismo , Indenos/química , Indenos/metabolismo , Ligandos , Ratones , Conformación Molecular , Relación Estructura-Actividad
4.
J Chromatogr A ; 799(1-2): 117-24, 1998 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-9550104

RESUMEN

High-performance liquid chromatography (HPLC) methods have been developed for the separation of substituted indenestrol A and B isomers on different columns. The isomers were separated by normal-phase liquid chromatography with a silica gel column. Enantiomers of these compounds were separated by chiral HPLC and the most successful separations were achieved with a Chiralcel OJ column.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Estrógenos no Esteroides/aislamiento & purificación , Indenos/aislamiento & purificación , Isomerismo
5.
J Med Chem ; 39(17): 3412-7, 1996 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-8765526

RESUMEN

Two series of thymidine analogs with a hydroxyalkylammonium(amine) moiety have been synthesized and evaluated for antitumor and antiviral activities. The hydroxyalkylammonium-(amine) group was introduced at the 5' position of the 2'-deoxyribose residue of thymidine or at a corresponding position in acyclic thymidine analogs. In order to increase the lipophilicity of these compounds and potentially enable them to cross the cell membrane, the free hydroxy group also was esterified with a long hydrocarbon chain. The hexadecanoyl analogs (compounds 1c, 1d, 7c, and 7d) showed moderate antitumor cytotoxicity against SV-28 and KB cell lines (IC50 approximately 20 microM). Compound 1d showed moderate anti-HIV activity (EC50 = 6.8 microM), while compound 5 showed weak anti-HIV activity (EC50 = 55 microM). None of the compounds showed antiherpes simplex virus activity.


Asunto(s)
Antineoplásicos/síntesis química , Antivirales/síntesis química , Timidina/análogos & derivados , Timidina/síntesis química , Animales , Antineoplásicos/química , Antineoplásicos/toxicidad , Antivirales/química , Antivirales/farmacología , División Celular/efectos de los fármacos , Línea Celular Transformada , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Cricetinae , VIH-1/efectos de los fármacos , Herpesvirus Humano 1/efectos de los fármacos , Humanos , Células KB , Espectroscopía de Resonancia Magnética , Estructura Molecular , Relación Estructura-Actividad , Timidina/química , Timidina/farmacología , Células Vero , Ensayo de Placa Viral
6.
J Med Chem ; 34(4): 1408-14, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-1901911

RESUMEN

Combinations of an amidoalkylphosphocholine, 8, and AZT have been found to cause an apparent synergistic action in suppressing infectious HIV-1 replication. In addition, amidoalkyl, oxyalkyl, and thioalkyl ether lipids have been chemically linked to anti-HIV-1 nucleosides (AZT and DDI) through phosphate and phosphonate linkages. These conjugates have shown promising in vitro anti-HIV-1 activity. Also, the conjugates have a 5-10-fold reduction in cell cytotoxicity compared to AZT alone. The most active compound, an amidoalkyl ether lipid-AZT conjugates, 4A, was found to have a differential selectivity of 1793 in a syncytial plaque assay. In comparison, AZT alone has a value of 1281.


Asunto(s)
Antivirales/síntesis química , Didanosina/análogos & derivados , Didanosina/síntesis química , VIH-1/efectos de los fármacos , Éteres Fosfolípidos/síntesis química , Zidovudina/análogos & derivados , Zidovudina/síntesis química , Línea Celular , Didanosina/química , Didanosina/farmacología , Didesoxinucleótidos , Éteres , VIH-1/fisiología , Humanos , Indicadores y Reactivos , Estructura Molecular , Éteres Fosfolípidos/química , Éteres Fosfolípidos/farmacología , Relación Estructura-Actividad , Replicación Viral/efectos de los fármacos , Zidovudina/química , Zidovudina/farmacología
7.
J Med Chem ; 34(4): 1377-83, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2016713

RESUMEN

A series of synthetic lipids containing a two- or three-carbon backbone substituted with a thio, oxy, or amidoalkyl functionality and either a phosphocholine or quaternary ammonium moiety was evaluated as potential anti-HIV-1 agents. Several analogues were identified as possessing activity with the most promising compound being rac-3-octadecanamido-2-ethoxypropylphosphocholine (8). Compound 8 exhibited an IC50 for the inhibition of plaque formation of 0.16 microM which was 84-fold lower than the IC50 value determined for CEM-SS cell growth inhibition. Initial mechanistic studies have indicated that these compounds, unlike AZT, are not reverse transcriptase (RT) inhibitors, but instead appear to inhibit a late step in HIV replication involving virus assembly and infectious virus production. Since these lipids are acting via a different mechanism, they represent an alternative approach to the chemotherapeutic treatment of AIDS as well as candidates for combination therapy with AZT.


Asunto(s)
Antivirales/síntesis química , VIH-1/efectos de los fármacos , Éteres Fosfolípidos/síntesis química , Compuestos de Amonio Cuaternario/síntesis química , División Celular/efectos de los fármacos , Línea Celular , Replicación del ADN/efectos de los fármacos , VIH-1/fisiología , Humanos , Indicadores y Reactivos , Espectroscopía de Resonancia Magnética , Estructura Molecular , Éteres Fosfolípidos/química , Éteres Fosfolípidos/farmacología , Compuestos de Amonio Cuaternario/química , Compuestos de Amonio Cuaternario/farmacología , Relación Estructura-Actividad , Ensayo de Placa Viral , Replicación Viral/efectos de los fármacos , Zidovudina/farmacología
8.
J Med Chem ; 33(3): 985-92, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2308148

RESUMEN

Alkylglycerols such as rac-1-O-octadecyl-2-O-methylglycerophosphochocholine (Et-18-OMe) have shown an inhibitory effect on the metastasis and growth of various cancer cell lines. Alkyl phospholipids have been shown to accumulate at the surface in several cell lines, the selectivity of which is still not clearly understood. A consequence of this action may lead to the inhibition of cell membrane related protein kinase C (PKC). The goal of this research was to develop ether lipid inhibitors of PKC to augment antineoplastic activity. This led to the synthesis and in vitro testing of a series of novel quaternary ammonium derivatives of alkylglycerols. The biological testing of these analogues on PKC stimulated with rac-1-O-oleoyl-2-O-acetylglycerol showed several analogues with inhibition comparable to that of Et-18-OMe.


Asunto(s)
Antineoplásicos/síntesis química , Éteres Fosfolípidos/síntesis química , Proteína Quinasa C/antagonistas & inhibidores , Antineoplásicos/farmacología , Diglicéridos/farmacología , Humanos , Fosfatidilserinas/farmacología , Éteres Fosfolípidos/farmacología , Relación Estructura-Actividad
9.
Pharm Res ; 6(3): 216-24, 1989 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2726677

RESUMEN

The synthesis of two novel glycero-3-phosphoinositol ether lipid analogues, rac-1-O-octadecyl-2-O-methylglycero-3-phospho-myo-inositol 6 (an ether lipid analogue of rac-1-O-octadecyl-2-O-methylglycero-3-phosphocholine; ET-18-OMe) and rac-1-O-octadecyl-2-O-acetylglycero-3-phospho-myo-inositol 11 (an ether lipid analogue of platelet-activating factor), is described. The two target compounds and the synthetic intermediates were evaluated for inhibition of HL60, BG1, and BG3 human malignant cells in vitro and inhibition of protein kinase C. Tumor inhibitory activity was found for compounds 6 and 11 in all systems but not for their synthetic intermediates. However, compounds 6 and 11 as well as the synthetic intermediates 5 and 13, but not 9, exhibited protein kinase C inhibitory activity.


Asunto(s)
Fosfatidilinositoles/síntesis química , Proteína Quinasa C/antagonistas & inhibidores , Células Tumorales Cultivadas/efectos de los fármacos , Fenómenos Químicos , Química , Humanos , Fosfatidilinositoles/farmacología
10.
Anticancer Res ; 8(6): 1361-6, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3218969

RESUMEN

1-0-Alkyl diol and glyceryl ether lipids with a quaternary ammonium polar head group were synthesized and the cytotoxicity (IC50) tested against KB cells, with low 1-0-alkyl-cleavage activity, and rat hepatoma 77 cells with relatively high 1-0-alkyl-cleavage activity. The original premise was that the compounds would be inactivated by the cleavage enzyme and thus be selectively toxic to cells with less of the enzyme. Results with two other cell lines with equivalent cleavage enzyme, HL-60 and K562-4, however, are not consistent with this premise.


Asunto(s)
Antineoplásicos/síntesis química , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Diglicéridos/síntesis química , Glicéridos/síntesis química , Éteres de Glicerilo/síntesis química , Animales , Antineoplásicos/farmacología , Línea Celular , Diglicéridos/farmacología , Éteres de Glicerilo/farmacología , Humanos , Células KB , Ratas , Relación Estructura-Actividad
11.
Biochem Pharmacol ; 35(20): 3587-91, 1986 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-3768041

RESUMEN

Several compounds have been tested for their ability to inhibit bovine pancreatic alpha-chymotrypsin (Ki) and their ability to inhibit cell replication (IC50). There is good agreement over three orders of magnitude between the Ki and the IC50 values of these compounds. The data support the hypothesis that a cellular, chymotrypsin-like activity is necessary for cell replication.


Asunto(s)
Quimotripsina/metabolismo , Inhibidores de Proteasas/farmacología , Animales , Ácidos Borónicos/farmacología , Bovinos , División Celular/efectos de los fármacos , Línea Celular , Cinética , Ratones , Páncreas/enzimología , Relación Estructura-Actividad
12.
Biochim Biophys Acta ; 484(1): 103-8, 1977 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-889840

RESUMEN

A group of arylalkylboronic acids were synthesized in order to investigate the inhibitory potential of these compounds for rat liver chromatin protease (EC 3.4--). The effect of side chain length, side chain substitution and aromatic substitution on proteolytic activity in chromatin dissociated in salt and urea was assayed. It was determined that a side chain length two carbons long provided the greatest inhibitory effect with complete inhibition attainable at 20 mM concentration of phenylethylboronic acid. Aryl substitution in the ortho position proved to be the most potent structural change with complete inhibition attained by 1 mM concentration of 0-methylphenylethylboronic acid. The binding of these two inhibitors proved to be reversible.


Asunto(s)
Ácidos Borónicos/farmacología , Hígado/enzimología , Inhibidores de Proteasas , Animales , Cromatina , Relación Dosis-Respuesta a Droga , Péptido Hidrolasas , Unión Proteica , Ratas , Relación Estructura-Actividad
14.
J Med Chem ; 19(2): 222-9, 1976 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1249803

RESUMEN

A series of 1,3-bis(substituted phenoxy)-2-propanones was found to be active hypocholesterolemic agents at 10 mg/kg/day. The p-chloro- and p-methyl-substituted phenoxy compounds possess the highest activity. These compounds did not possess the estrogenic and antifertility activities of the related previously reported derivatives of the bis(beta-phenylethyl) ketone series. The 1,3-bis(p-methylphenoxy)-2-propanone (7) also lowered serum triglycerides and glycerol which appeared to be due to increased levels of serum lipase and reduced activity of liver lipase. There was reduced incorporation of free fatty acids into complex lipids by the liver. Cholesterol was excreted faster in the treated animals.


Asunto(s)
Anticolesterolemiantes/síntesis química , Propano/análogos & derivados , Animales , Anticolesterolemiantes/farmacología , Peso Corporal/efectos de los fármacos , Colesterol/sangre , ADN/metabolismo , Depresión Química , Femenino , Fertilidad/efectos de los fármacos , Lipasa/metabolismo , Metabolismo de los Lípidos , Hígado/enzimología , Hígado/metabolismo , Glucógeno Hepático/metabolismo , Masculino , Ratones , Tamaño de los Órganos/efectos de los fármacos , Éteres Fenílicos/síntesis química , Éteres Fenílicos/farmacología , Propano/síntesis química , Propano/farmacología , Proteínas/metabolismo , ARN/metabolismo , Ratas , Útero/efectos de los fármacos
15.
Biochim Biophys Acta ; 409(2): 218-24, 1975 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-1191664

RESUMEN

An unnatural phospholipid, phosphatidyl-N-isopropylethanolamine, was isolated from rat liver after intraperitoneal injections of N-isopropylethanol-amine; it was identified on the basis of enzymic, chemical, and chromatographic analyses. Although this phospholipid was formed at the expense of phosphatidylcholine and phosphatidylethanolamine, its fatty acid composition did not resemble either of these lipids. Microsomes, mitochondria, and plasma membranes contained significant amounts (up to 9%) of this unusual phospholipid. Radioisotope incorporation experiments suggest that the N-isopropylethanol-amine containing phospholipid is rapidly equilibrated between microsomes and mitochondria and more slowly with surface membranes.


Asunto(s)
Etanolaminas/metabolismo , Hígado/metabolismo , Fosfatidiletanolaminas/metabolismo , Animales , Cromatografía en Capa Delgada , Masculino , Fosfatidiletanolaminas/análogos & derivados , Fosfolípidos/biosíntesis , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA